U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H17NOS
Molecular Weight 307.409
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TOLNAFTATE

SMILES

CN(C(=S)OC1=CC=C2C=CC=CC2=C1)C3=CC=CC(C)=C3

InChI

InChIKey=FUSNMLFNXJSCDI-UHFFFAOYSA-N
InChI=1S/C19H17NOS/c1-14-6-5-9-17(12-14)20(2)19(22)21-18-11-10-15-7-3-4-8-16(15)13-18/h3-13H,1-2H3

HIDE SMILES / InChI

Molecular Formula C19H17NOS
Molecular Weight 307.409
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3524433

Tolnaftate is a thiocarbamate derivative used as an over-the-counter anti-fungal agent for treatment of athlete's foot and ringworm. Tolnaftate acts by inhibition of ergosterol biosynthesis pathway in fungal cells.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q92206
Gene ID: 3646458|||3646509
Gene Symbol: ERG1
Target Organism: Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
TINACTIN

Approved Use

Treatment of tinea corporis (body ringworm) and tinea cruris (jock itch) caused by Epidermophyton floccosum, Microsporum canis, M. audouinii, Trichophyton mentagrophytes, T. rubrum, or T. tonsurans.
Curative
TINACTIN

Approved Use

Treatment of tinea corporis (body ringworm) and tinea cruris (jock itch) caused by Epidermophyton floccosum, Microsporum canis, M. audouinii, Trichophyton mentagrophytes, T. rubrum, or T. tonsurans.
Curative
TINACTIN

Approved Use

Treatment of tinea pedis (athlete’s foot) and tinea manuum (hand ringworm) caused by E. floccosum, M. canis, M. audouinii, T. mentagrophytes, T. rubrum, or T. tonsurans.
Curative
TINACTIN

Approved Use

Treatment of tinea pedis (athlete’s foot) and tinea manuum (hand ringworm) caused by E. floccosum, M. canis, M. audouinii, T. mentagrophytes, T. rubrum, or T. tonsurans.
Curative
TINACTIN

Approved Use

Treatment of pityriasis (tinea) versicolor caused by Malassezia furfur (Pityrosporum orbiculare or P. ovale).
PubMed

PubMed

TitleDatePubMed
FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
2013-09-05
Targeted protein depletion in Saccharomyces cerevisiae by activation of a bidirectional degron.
2010-12-29
Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.
2010-10-27
Sli15(INCENP) dephosphorylation prevents mitotic checkpoint reengagement due to loss of tension at anaphase onset.
2010-08-10
Identification of Hedgehog signaling inhibitors with relevant human exposure by small molecule screening.
2010-08
Assay of tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography.
2010-07-20
Development of high-yield autofluorescent protein microarrays using hybrid cell-free expression with combined Escherichia coli S30 and wheat germ extracts.
2010-06-15
One-hit wonders of genomic instability.
2010-05-19
Current concepts in systemic and topical therapy for superficial mycoses.
2010-03-04
Otomycosis: Diagnosis and treatment.
2010-03-04
Both interaction surfaces within cohesin's hinge domain are essential for its stable chromosomal association.
2010-02-23
Proteasome nuclear activity affects chromosome stability by controlling the turnover of Mms22, a protein important for DNA repair.
2010-02-19
In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.
2010-02-03
Fungicide-driven evolution and molecular basis of multidrug resistance in field populations of the grey mould fungus Botrytis cinerea.
2009-12
Trichomycoses.
2009-07
Label-free detection of drug-membrane association using ultraviolet-visible sum-frequency generation.
2009-02-04
Conserved features of cohesin binding along fission yeast chromosomes.
2009
Efficient protein depletion by genetically controlled deprotection of a dormant N-degron.
2009
PTTG: an important target gene for ovarian cancer therapy.
2008-10-20
Heterologous expression of plasmodial proteins for structural studies and functional annotation.
2008-10-01
Are placebo-controlled trials of creams for athlete's foot still justified?
2008-09
Functional characterization of cohesin subunit SCC1 in Trypanosoma brucei and dissection of mutant phenotypes in two life cycle stages.
2008-08
E1 ubiquitin-activating enzyme UBA-1 plays multiple roles throughout C. elegans development.
2008-07-18
RIP and RALyase cleave the sarcin/ricin domain, a critical domain for ribosome function, during senescence of wheat coleoptiles.
2008-06-13
Cell-type-specific TEV protease cleavage reveals cohesin functions in Drosophila neurons.
2008-02
Inhibitory phosphorylation of separase is essential for genome stability and viability of murine embryonic germ cells.
2008-01
Displacement and re-accumulation of centromeric cohesin during transient pre-anaphase centromere splitting.
2007-12
Topical treatments for fungal infections of the skin and nails of the foot.
2007-07-18
Polo-like kinase controls vertebrate spindle elongation and cytokinesis.
2007-05-02
Identification of the C. elegans anaphase promoting complex subunit Cdc26 by phenotypic profiling and functional rescue in yeast.
2007-03-20
A multi-step pathway for the establishment of sister chromatid cohesion.
2007-01-19
PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines.
2007
ProFAT: a web-based tool for the functional annotation of protein sequences.
2006-10-23
The eggshell is required for meiotic fidelity, polar-body extrusion and polarization of the C. elegans embryo.
2006-10-16
[Use of topical antifungal agents].
2006-09-23
Study on the supramolecular multirecognition mechanism of beta-naphthol/beta-cyclodextrin/anionic surfactant in a tolnaftate hydrolysis system.
2006-05-04
Highly sensitive and selective spectrofluorimetric determination of tolnaftate through the formation of ternary inclusion complex of beta-naphthol/beta-cyclodextrin/anionic surfactant system.
2006-03-15
Nuclear distribution and chromatin association of DNA polymerase alpha-primase is affected by TEV protease cleavage of Cdc23 (Mcm10) in fission yeast.
2005-06-07
The identification of foam-forming soluble proteins from wheat (Triticum aestivum) dough.
2005-04
Shugoshin prevents dissociation of cohesin from centromeres during mitosis in vertebrate cells.
2005-03
Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2.
2005-03
Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.
2004-12
Validation of a liquid chromatography assay for the quantification of the Raf kinase inhibitor BAY 43-9006 in small volumes of mouse serum.
2004-09-25
Tolnaftate spray treatment during pregnancy.
2004-05
[Antimycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis].
2004
Involvement of fatty acid pathways and cortical interaction of the pronuclear complex in Caenorhabditis elegans embryonic polarity.
2003-10-03
A study of dermatophytes and their in-vitro antifungal sensitivity.
2002-04
Ergosterol biosynthesis inhibition: a target for antifungal agents.
1995
[Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].
1991-02
Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
1986-05
Patents

Sample Use Guides

Apply topically to the infected skin as a 1% cream, aerosol liquid spray, aerosol powder spray, powder, or solution.
Route of Administration: Topical
In Vitro Use Guide
Ergosterol biosynthesis in fungal cells from Candida albicans, Candida parapsilosis and Trichophyton mentagrophytes was measured by incubation of cells were incubated with [U-14C]acetate at pH 6.5 for 2 hrs and quantification of nonsaponifiable lipids by thin layer chromatography. Tolnaftate inhibited ergosterol biosynthesis with IC50 of about 0.1-1.0 mg/l.
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:36:50 GMT 2025
Edited
by admin
on Mon Mar 31 17:36:50 GMT 2025
Record UNII
06KB629TKV
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TOLNAFTATE
EP   GREEN BOOK   INCI   INN   MART.   MI   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN   INN   INCI  
Official Name English
SEPARIN
Preferred Name English
NSC-233648
Code English
TOLNAFTATE [VANDF]
Common Name English
TOLNAFTATE [EP MONOGRAPH]
Common Name English
O-2-NAPHTHYL M,N-DIMETHYLTHIOCARBANILATE
Common Name English
SCH 10144
Code English
TOLNAFTATE [USP-RS]
Common Name English
CARBAMOTHIOIC ACID, METHYL(3-METHYLPHENYL)-, O-2-NAPHTHALENYL ESTER
Common Name English
SCH-10144
Code English
Tolnaftate [WHO-DD]
Common Name English
tolnaftate [INN]
Common Name English
TOLNAFTATE [JAN]
Common Name English
TOLNAFTATE [MI]
Common Name English
TOLNAFTATE [USP MONOGRAPH]
Common Name English
TOLNAFTATE [GREEN BOOK]
Common Name English
TOLNAFTATE [USAN]
Common Name English
TOLNAFTATE [MART.]
Common Name English
Classification Tree Code System Code
WHO-VATC QD01AE18
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
CFR 21 CFR 524.2350
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
EPA PESTICIDE CODE 122901
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
NCI_THESAURUS C514
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
WHO-ATC D01AE18
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
CFR 21 CFR 333.210
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
Code System Code Type Description
CHEBI
9620
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
PUBCHEM
5510
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
RXCUI
10637
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY RxNorm
DRUG CENTRAL
3617
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
EVMPD
SUB11163MIG
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
EPA CompTox
DTXSID3042477
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
SMS_ID
100000077758
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
NCI_THESAURUS
C47763
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
ChEMBL
CHEMBL83668
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
INN
1730
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
ECHA (EC/EINECS)
219-266-6
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
WIKIPEDIA
TOLNAFTATE
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
DAILYMED
06KB629TKV
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
NSC
233648
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
RS_ITEM_NUM
1671006
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
LACTMED
Tolnaftate
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
MESH
D014047
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
MERCK INDEX
m10948
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY Merck Index
CAS
2398-96-1
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
DRUG BANK
DB00525
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
FDA UNII
06KB629TKV
Created by admin on Mon Mar 31 17:36:50 GMT 2025 , Edited by admin on Mon Mar 31 17:36:50 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
ACTIVE MOIETY